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ABSTRACT  
Endocrine disruptors (EDs) is a large group of compounds, usually present as 
environmental pollutants, that can alter the homeostasis of living organisms modifying 
the hormonal balance and changing the normal patterns of gene regulation during 
development and cell differentiation. Hence, the development of male gonads and their 
functionality may be affected by exposure to specific EDs or their mixtures. The 
molecular mechanisms of action of these reprotoxicants leading to pathologies of the 
reproductive system such as testicular cancer, are complex and not well characterized. It 
is likely, however, that these compounds alter the interaction between the mechanisms 
of gene regulation and functional gene networks in windows of risk, mainly during 
embryonic development. Moreover, such changes could be transmitted through 
generations by epigenetic mechanisms. There are examples of the action of EDs on the 
expression of mRNAs, small non-coding RNAs and epigenetic marks on the developing 
testis associated to cellular and molecular alterations found in germ cell tumors. In the 
present review, we will discuss various aspects of genetic, transcriptomic and epigenetic 
changes related to testicular development, exposure to EDs and the occurrence of germ 
cell tumors. 
 
Introduction 
Testis development involves a series of processes of differentiation from early 
embryogenesis, mainly based in mammals on genetic determinants of male on 
chromosome Y. Mechanisms of germ and Sertoli cell differentiation, lead to the 
formation of seminiferous tubules that along with the intertubular Leydig cells form the 
cellular network of spermatogenesis. Autocrine, paracrine and endocrine regulations and 
precise specific gene expression allow setting the appearance of male characters and the 
continuous production of sperm in adult life (Brennan and Capel, 2004; Park and 
Jameson, 2005). 
Spermatogenesis involves complex processes of proliferation, differentiation, cell 
interactions and morphogenetic changes to produce highly differentiated and haploid 
cells such as in spermatozoa. Although the time course of cell differentiation can be very 
variable among different mammals, basic traits of spermatogenesis at the cellular and 
molecular levels, as well as the developmental progression are comparable; this enables 
predictions using animal models of study. The exclusive nature of some of these 
processes requires developmentally orchestrated control of gene expression. It has been 
estimated that about 4% of the mouse genome, representing above 2300 genes, is 
specifically expressed in testis (Schultz et al., 2003). In addition, alternative forms of 
post-transcriptional regulation of gene expression such as alternative splicing (Yeo et al., 
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2004), different polyadenilation sites and thus 3’-UTRs (Parraga and del Mazo, 2000; 
Wang et al., 2006), and differences in the length of poly(A) tails of mRNAs (de Luis and 
del Mazo, 1998), are frequent in testicular germ cell differentiation.  
 The recent developments in the “world of small RNAs” are causing a revolution 
in our knowledge of gene regulation. RNA interference mediated by small non-coding 
RNAs is a powerful mechanism in the control of gene expression associated with cell 
differentiation and pathologies. In germ cells, three types of endogenous small RNAs, 
microRNAs (miRNAs), piwi-interacting RNAs (piRNAs) (initially considered specific of 
germ cells) and endogenous small interfering RNAs (endo-siRNAs), with cell-type 
regulated biogenesis (Gonzalez-Gonzalez et al., 2008; Garcia-Lopez and del Mazo, 2012), 
are being studied to determine their role in the differentiation of germ cells and its 
pathologies, including infertility and testicular cancers (He et al., 2009). 
The cells and biological systems can be affected by environmental contaminants 
through alterations of genetic systems, by multiple mechanisms of action also interacting 
with the genetic backgrounds (Edwards and Myers, 2007). The adverse effect of 
environmental pollutants on reproductive health is well documented (Woodruff et al., 
2008). An important and extensive group of chemical contaminants, widespread in the 
environment, is called endocrine disruptors (EDs). These are wide groups of chemical 
compounds such as: pesticides and herbicides, organic compounds, pharmacological 
substances, heavy metals, persistent organic pollutants, air contaminants that interfere 
with endocrine pathways and can induce gene deregulation in exposed organisms. To date, 
hundreds of compounds considered EDs and thousands of others are suspected of having 
similar properties have been identified. The testis has been clearly identified as a 
significant target for the deleterious action of these environmental toxicants. This 
knowledge generates worldwide concern as to consequences for reproductive health both 
in humans and wild species (Colborn and Clement, 1992). The causal relationship 
between endocrine disruption by environmental chemicals and disorders such as cancer 
and infertility has been the subject of numerous scientific reports. A classical, albeit 
contested, report (Toppari et al., 1996) reached the conclusion that there has been a 
general, although not necessarily global decline in semen quality during the last fifty years 
as was previously reported (Carlsen et al., 1992). The report also showed that 2-4% of 
the annual increase in testicular cancer was diagnosed in men under 50 years old in 
Britain, Scandinavia, Australia and the USA. Epidemiological and experimental data 
indicate that developmental exposure to EDs could induce, at the level of male gonad 
development and reproduction, the so-called “Testicular Dysgenesis Syndrome” (TDS) 
(Sharpe and Skakkebaek, 1993; Skakkebaek et al., 2001). TDS includes four clinical and 
etiologically related traits: hypospadias, cryptorchidism, low sperm counts and testicular 
tumors (Asklund et al., 2004). The impact of EDs, however, is still unclear due to the 
wide range of possible mechanisms for ED action, levels of ED exposure, mixture of 
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chemicals potentially acting as EDs and the genetic sensibility of individuals or 
populations to the compounds.  
The effects in germ cells not only may affect the exposed individual but can also 
be inherited and potentially influence the phenotype of subsequent generations by 
epigenetic mechanisms. The term “epigenetic”, introduced by C.H. Waddington (1905-
75) to describe interactions of genes with their environment (Waddington, 1942), is now 
used to define heritable changes in gene expression that are not coded in the DNA 
sequence. Main epigenetic mechanisms include DNA methylation and histone 
modifications (Kim et al., 2009). More recently, additional mechanisms have been 
identified, among them microRNAs (miRNAs) can act on the epigenetic machinery, and 
in turn miRNA expression can also be controlled by epigenetic mechanisms (Sato et al., 
2011). The epigenetic patterns can be transmitted to the daughter cell, and possibly also 
through generations. In turn, deregulation of miRNAs can affect the regulation of 
expression of mRNA targets, generating complex mechanisms of alterations with 
pathological consequences in testis development and function. 
 
Developmental origin of testicular germ cell tumors 
Testicular germ cell tumors (TGCTs) are the most common solid cancers in men 
aged 15–40 years in developed countries (Huyghe et al., 2003; Hussain et al., 2008), 
constituting 2% of all human malignancies (Richiardi et al., 2004; Motzer et al., 2012) 
and representing the most frequent cause of death as a consequence of solid tumors in this 
age group (Oosterhuis and Looijenga, 2005). Germ cell tumors represent about 95% of 
malignant tumors arising in the testes whereas only 1-5% of the testicular cancers have 
their origin on somatic components of the testis: Sertoli and Leydig cells (Mostofi, 1973; 
Giglio et al., 2003). During the last five decades the prevalence of these tumors increased 
2-3 times and each year about 9,000 new cases of TGCTs are diagnosed in USA (Siegel et 
al., 2012).  
TGCTs consist of a heterogeneous group of neoplasms, established at different 
anatomical locations in the testis. Simplistically, TGCTs can be classified in seminomas 
(SGCTs) and non-seminomas (NSGCTs). Seminomas have features of  the primordial 
germ cells (PGCs) or gonocytes, the ancestors of spermatogonia while non-seminomas 
include mixed germ cell tumors (the most common), embryonal carcinoma, teratoma, 
choriocarcinoma, and yolk sac tumors.  
The fetal origin of some types of TGCTs is widely supported (Rajpert-De Meyts 
et al., 1998; Looijenga et al., 2007b; Kristensen et al., 2008; Wohlfahrt-Veje et al., 
2009). Due to their physiological and genetic similarities, PGCs are considered the cell 
origin of the TGCTs (Rajpert-De Meyts, 2006). Indeed, seminomas have clear features 
of PGCs (see below) (Jiang and Nadeau, 2001; Oosterhuis and Looijenga, 2005; Gilbert et 
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al., 2011). Both seminomas and teratocarcinomas derived from abnormal germ cells that 
initiate within the seminiferous epithelium as carcinoma in situ (Skakkebaek, 1972). 
Carcinoma in situ and embryonic stem cell display similar profiles of gene expression 
(Almstrup et al., 2004). 
Although controversial (Vidaeff and Sever, 2005), epidemiological studies in 
humans associate the exposure to different environmental toxicants with the 
development of TGCTs. Epidemiological studies support the hypothesis that testicular 
cancer is associated with exposure to some EDs, at least to estrogens (Storgaard et al., 
2006), during the fetal or early postnatal life. Exposures to persistent organochlorine 
pesticides (POPs) have been associated to risk increase of seminomas and non-
seminomas testicular cancers (McGlynn et al., 2008). However, no association with 
exposure to polychlorinated biphenyls (PCBs) (even, inverted association) was detected 
(McGlynn et al., 2009), speculatively explained by the wide range of effects of the 
different PCBs and mixes (estrogenic, antiestrogenic, androgenic, and antiandrogenic),  
The Sertoli cells as somatic components of the seminiferous epithelium play a 
pivotal role in the development of a functional testis, and as consequence in the 
development of the male phenotype (Skinner and Griswold, 2005). Their direct 
interaction with male germ cells into the seminiferous epithelium is crucial during 
spermatogenesis. Disorders in the correct maturation or numbers of Sertoli cells thus may 
be the cause of male reproductive disorders (reviewed by Sharpe et al., 2003). Similarly, 
the Leydig cell represents a crucial element of testis functions, basically through the 
secretion of androgens (Payne et al., 1996). The effects of EDs on such cells are 
considered of special relevance due to hormonal regulation of Sertoli and Leydig cells 
functions and by the hypothesis that the TDS could be mainly caused by functional 
disorders in Sertoli and Leydig cells (Sharpe et al., 2003). However, dysregulation of gene 
expression in these cell types as consequence of ED exposures seems to cause 
dysfunctions in traits of TDS other than testicular cancer. Therefore, Sertoli or Leydig 
cells tumors will not be discussed in this review. 
Genetic background of testicular germ cell tumors 
From the genetic point of view, chromosomal unbalance is usually found in 
diverse forms of TGCT. The most common cytogenetic alteration is the amplification 
of human chromosome 12p region (Looijenga et al., 2003b; Rodriguez et al., 2003; 
Zafarana et al., 2003; von Eyben, 2004). Different TGCTs show particular chromosome 
abnormality pattern. While in non-seminoma germ cell tumors gain of proximal 17q and 
loss of 10q have been usually detected (Mohamed et al., 2012), seminomas show high-
level amplification of 12p (Zafarana et al., 2003; Mohamed et al., 2012). Interestingly, 
this chromosome region contains multiple genes postulated to be involved in TGCT, such 
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as CCND2, STELLAR and NANOG, expressing in PGCs and playing important roles in 
stem cell maintenance (Houldsworth et al., 2006). 
Compared to chromosomal abnormalities, specific gene mutations in TGCT are 
less frequent. The most frequent single genes affected in TGCTs are: KIT, TP53, K-RAS, 
N-RAS, and B-RAF (reviewed bySheikine et al., 2012). Genetic susceptibility to TGCTs 
conditioning the familial testicular germ cell tumors has been established, confirming 
mutations or single nucleotide polymorphisms (SNPs) affecting some genes involved in 
the normal germ cell differentiation such as KITLG, SPRY4, PDE11A and BAK1 (Greene 
et al., 2010). 
Genetic susceptibility to TGCTs by exposure to some types of EDs is currently 
being studied more intensively. Genetic polymorphism in humans, such as those found on 
hormone-metabolizing genes including CYP17A1 and HSD17B1, can also modified the 
association between TGCT risk and exposure to specific EDs such as POPs (Chia et al., 
2010). The combination of genotyping and transcriptome analysis (named genetical 
genomics) could differentiate the genetic from the environmental components of gene 
expression variations (Gibson, 2008). After genome-wide association (GWA) studies, new 
approaches based on gene–environment (G×E) interactions methodology (Thomas, 
2010; van Ijzendoorn et al., 2011) will probably contribute to clarify the complex 
pathways involving multiple genes and exposures. 
Comparing gene expression in PGCs and testicular germ cell neoplasias 
In mammals, PGCs are the embryonic precursors of both female and male germ 
cells (De Felici, 2001). As we are going to discuss below, in the mouse embryo, PGCs are 
determined in the extraembryonic mesoderm of the yolk sac wall around the gastrulation 
period (6.5 days post coitum, dpc; and around the third week of gestation in humans) 
(McLaren, 2003; Saitou et al., 2003; De Felici, 2012). From this region, they migrate 
within the developing gonadal ridges where they differentiate into female or male germ 
cells. Within the fetal testis, PGCs after a proliferation period exit temporarily from the 
cell cycle and are arrested in G0. Such quiescent cells included inside seminiferous cords 
are now called prespermatogonia or gonocytes. The sexual dimorphism of the mouse 
gonads is evident at 12.5-13.5 dpc (Fig. 1). Spermatogonial stem cells (SSCs) of the 
newborn and prepuberal testis derive from gonocytes although the processes of their 
differentiation from these cells are unknown. SSCs can self-renew and generate a large 
number of differentiated germ cells. In particular, they give rise to type A spermatogonia 
which after some rounds of proliferation differentiate into type B spermatogonia; these 
latter entering into meiosis become spermatocytes. After meiotic divisions, haploid 
spermatids are produced, suffering morphogenetic changes until their subsequent 
differentiation into spermatozoa. 
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The transcriptional repressor BLIMP1 (B-lymphocyte-induced maturation 
protein 1) participates in the initial specification of PGCs repressing their somatic 
program (Saitou et al., 2003; McLaren and Lawson, 2005; Ohinata et al., 2005; Vincent  
et al., 2005). Subsequently, PGCs move from the proximal epiblast to the 
extraembryonic mesoderm of the yolk sac wall and then through the hindgut and dorsal 
mesentery to the gonadal ridges (11.5 dpc in mice and the 6th week in humans) (Godin et 
al., 1991; Wylie, 1993; Donovan, 1994; Runyan et al., 2006; Sheikine et al., 2012). 
During this period, PGC development is regulated by a variety of growth factors and 
cytokines including BMPs (bone morphogenic proteins), Kit ligand (KITLG), also known 
as the stem cell factor (SCF), and SDF1 (stromal cell derived-1) (for a review, see (De 
Felici and Farini, 2012). PGCs and gonocytes express several markers typical of stem 
cells such as TNAP (tissue not specific alkaline phosphatase), NANOG, ESG1, SOX2, 
POU5F1 (also known as OCT3/4), and SALL4 (Saitou et al., 2002; Saitou et al., 2003; 
Gashaw et al., 2007; Niwa, 2007), as well as germ cell specific such as MVH, NOBOX, 
DAZL, NANOS3 (reviewed by De Felici, 2009). PGCs and in part gonocytes have their 
original genomic imprinting pattern erased, which allows development of gender-specific 
germ cell lineages. PGCs maintain intrinsic pluripotency up to their differentiation into 
oocytes and gonocytes as shown by their capability to produce 
teratomas/teratocarcinoma or embryonal germ (EG) cells (for a review, see(Donovan and 
de Miguel, 2003).  
It is likely that at least in part PGC intrinsic pluripotency depends on the 
methylation status of imprinted genes such as H19, IGF2, IGF2R and SNRPM (Szabo 
and Mann, 1995). The loss of imprinting in PGCs could be considered as one of the 
pathways implied in their differentiation and loss of pluripotency. In the presence of the 
Y chromosome, the gonadal stromal cells of the gonadal ridges express the transcription 
factor SRY and its target gene SOX9 driving Sertoli cell differentiation (Polanco and 
Koopman, 2007). The Sertoli cells create a microenvironment that allows 
differentiation of gonocytes into SSCs. During the differentiation process, germ cells 
gradually lose expression of NANOG, PLAP, and POU5F1, partially of KIT and SALL4, 
and acquire expression of other genes including MAGE4A, and TSPY (Cao et al., 2009). 
Gene signature of deregulation in TGCTs respect to normal male germ cells has been 
reported based on array analysis in different histological entities of TGCTs (Okada et al., 
2003; Gashaw et al., 2005). These studies have associated patterns of deregulation of 
specific genes as potential molecular markers of gene expression that define types of 
TGCTs and prognosis of such tumors (Gashaw et al., 2005). One feature that could 
define the fetal origin of TGCTs is the similarity of the patterns of gene expression 
between PGCs/gonocytes and neoplasic cells of testicular tumors (Almstrup et al., 2004). 
Analysis by cDNA microarrays defined expression profile of 895 genes that were 
upregulated in human embryonal stem (ES) cells and carcinoma lines respect to the 
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controls, showing highest expression the OCT3/4 gene and confirming the hypothesis 
that human seminomas most closely resemble transformed PGCs (Sperger et al., 2003). 
Interestingly, high representations of deregulated genes are localized on the 12p 
chromosome region. 
In humans, seminomas, embryonal carcinoma, carcinoma in situ (CIS) and yolk 
sac tumors show expression of OCT3⁄4 (Palumbo et al., 2002; Looijenga et al., 2003a; de 
Jong et al., 2005; Richie, 2005; Jung et al., 2006), NANOG (Hart et al., 2005; Hoei-
Hansen et al., 2005) and LIN28 (West et al., 2009; Gillis et al., 2011) which are not 
detectable in either normal testicular tissue or in teratomas. During development of 
human germ cell, the genes OCT3⁄4, NANOG and LIN28 are expressed in PGCs and 
gonocytes being LIN28 extended to prespermatogonia (Yeom et al., 1996; Brehm et al., 
1998; Gillis et al., 2011), amongst others involved in pluripotency (Nichols et al., 1998). 
In mouse, LIN28 regulates the expression of members of the family of miRNA: miR-let-
7 (Hagan et al., 2009), which potentially regulates other multiple potential mRNA 
targets. The regulation of specific gene expression during early development is also 
mediated by DNA methylation as occurs in the expression of OCT3⁄4 (Gidekel and 
Bergman, 2002) whose expression levels appear a crucial key in the neoplasic process 
(Gidekel et al., 2003). Other functional markers of gene expression in TGCTs common 
to early differentiated germ cells and CIS, are PLAP (Hustin et al., 1987) and c-KIT 
(Rajpert-De Meyts and Skakkebaek, 1994; Strohmeyer et al., 1995; Honecker et al., 
2004; Motzer et al., 2012). 
In contrast to other cancers, there are few animal models of TGCTs. In mouse, the 
only strain that developed TGCTs, and which also proved to originate from PGCs is the 
129/SvJ strain, discovered by more than 50 years ago by Stevens (Stevens and Little, 
1954; Stevens and Hummel, 1957; Stevens, 1962; Stevens, 1964; Stevens, 1967; Stevens, 
1973; Stevens, 1984). More recently, it has identified mutations in the mouse 
homologous gene of zebrafish (Weidinger et al., 2003): dead end homolog 1 (Dnd1) gene 
as an inducer of this phenotype (Matin and Nadeau, 2005; Youngren et al., 2005). Dnd1 
encodes a protein participating in the “editosome” with activity of RNA-binding protein 
(Youngren et al., 2005). RNA editing is a post transcriptional key regulator of gene 
expression (Keegan et al., 2001) that generate alternative RNAs including mRNAs and 
double stranded RNAs such as are the miRNAs precursors (Nishikura, 2010). Recently, it 
has been reported the binding of Dnd1 to transcripts encoding negative regulators of the 
cell-cycle, involved in developing male germ cell mitotic arrest (Western et al., 2008), 
such as: p21Cip1, p27Kip1, Lats2, pRB, p53 and Pten promoting translation regulation 
(Cook et al., 2011) as was previously suggested (Western, 2009). Experimental deletion 
of Pten in PGCs drives to testicular teratomas and abnormal germ cell proliferation 
(Kimura et al., 2003; Moe-Behrens et al., 2003). It has been proposed that a regulatory 
mechanism of Dnd1 is based on the protection of specific transcripts, as those 
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mentioned, to the negative post-transcriptional regulation of miRNAs. In this view, the 
binding of the transcripts to 3’ UTR regions protects for the binding and activity of 
miRNA competing for the same mRNA regions, as was observed in zebrafish where Dnd1 
protein is able to protect Nanos from the negative translation regulatory action of miR-
430 during PGC development (Kedde et al., 2007). Combining both potential activities 
of Dnd1, a dual action of Dnd1 can be hypothesized: modification the sequence of 
miRNAs in their biogenesis and therefore divert them from their initial target, or 
alternatively competition with the target miRNAs. Consequently, complex regulatory 
mechanisms at postranscriptional level could also be involved in the genetic program of 
germ cells development in the embryo being their unbalance involved in testicular 
tumorogenesis.  
Effects of endocrine disruptors on gene expression in PGCs and developing testis 
Studies of transcriptome changes in testicular cells after chemical exposure have 
been carried out in mouse models using both in vitro and in vivo approaches. In vitro 
analysis allows to define changes of gene expression in specific cell types. Yet, the in 
vitro approaches create a handicap due to the removal in isolating cells from their natural 
physiological conditions. This method also is valid for cell types present in the precise 
time frame during testis development such as PGCs. For example, the level of AKT 
kinase activity, that is induce by phosphorylation of the KIT-ligand, crucial for PGC 
survival/proliferation, significantly decreased in mouse PGCs exposed to lindane (gamma-
HCH) in vitro along with the increase in the number of apoptotic PGCs induced by 
lindane either in culture and in the embryo (La Sala et al., 2009). Moreover, in a similar 
in vitro assay 17-beta-estradiol (E2) was able to rapid stimulation of AKT, KIT ERK2 
and SRC phosphorylation in mouse PGCs (La Sala et al., 2010).  
Others in vitro studies have shown differential response of PGCs to toxicants with 
different mechanisms of action. In vitro cultured PGCs exposed to N-ethyl-N-nitrosourea 
(ENU) (a classical toxicant and mutagen, with effects on spermatogenic cells) (Lessard et 
al., 2004) or Doxorubicin (trade name Adramycin, ADR) an anthracycline widely used in 
cancer therapy, with apoptotic effects on spermatogenic cells (Sjoblom et al., 1998) 
demonstrated growth inhibition and apoptosis induction, whereas exposure to mono (2-
ethylhexyl) phthalate (MEHP) (the direct metabolite of the di (2-ethylhexyl) phthalate 
or DEHP), a widespread plasticizer, ubiquitously found as environmental pollutant 
affected PGC adhesion to cell monolayers (Iona et al., 2002).   
In order to identify gene deregulation as early response to different toxicants 
cDNA libraries prepared from limited amount of cells followed by differential screening 
showed highly altered gene expression in PGCs after exposure in vitro to EDs (Table 1) 
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(our unpublished data). Most of deregulated genes detected encode proteins involved in 
pathways basic for cell survival: respiratory chain and oxidative stress, ribosomal 
proteins, metabolism of the cell and translation factors. The relationship between 
mitochondrial reactive oxygen species (ROS) and survival/cell death is well established 
(Orrenius, 2007) and was classically related to fertility impairment (Sikka et al., 1995). 
The survival of mammalian cells exposed to adverse environmental conditions requires a 
radical reprogramming of protein translation (Yamasaki and Anderson, 2008).  
Studies of gene expression deregulation caused by environmental reprotoxicant 
exposure on testis, including EDs, have focused on the analysis of specific genes and 
defined genetic pathways (Richburg et al., 2002; Edwards and Myers, 2007). The use of 
DNA microarray technology has implemented the understanding of the molecular basis 
of the effects EDs and other toxicants (Francois et al., 2003; Iguchi et al., 2006; Iguchi 
et al., 2007). Vinclozolin is a known ED, used as fungicide, with antiandrogenic activity 
(Kelce et al., 1994). Analysis by microarrays of changes in the transcriptome of embryo 
testes from rats exposed during embryonic period to vinclozolin showed altered 
expression of 576 genes in embryo at 13-16 dpc (Clement et al., 2010). Gene expression 
deregulation can be based on epigenetic mechanisms as was reported by the same research 
team (Anway et al., 2005; Anway et al., 2006). Some of the deregulated genes are close 
related with cancer development such as the tumor suppressor HIC2 (hypermethylated in 
cancer 2). 
Recently, we also reported a comparative analysis of the effect of different EDs on 
gene expression in developing testis, assessing at the same time dosage and 
developmental periods of exposure (Lopez-Casas et al., 2012). Five compounds of 
different nature, but all considered as ED, were analyzed. 17beta-estradiol (E2), as a 
natural estrogen; lindane, as one of the oldest synthetic pesticides still in use worldwide; 
mono-(2-ethylhexyl) phthalate (MEHP), bisphenol A (BPA) as a worldwide 
environmental contaminant and zearalenone (ZEA) a non steroidal estrogenic 
mycotoxin. Experimental deleterious effects of each of these compounds have been 
widely reported. The experimental plan included in vivo exposure of mice to several 
doses of EDs following a defined protocol: mothers were exposed two weeks before 
mating; the same exposure and dose were maintained during pregnancy and four weeks 
after birth. The results indicated that the different EDs act during testis development and 
germ cell differentiation with different mechanisms and diverse molecular pathways, as 
shown by their patterns of gene expression deregulation. MEHP and ZEA exposures 
define specific gene expression signatures after unsupervised hierarchical clustering 
analysis of 2670 genes. The pattern of deregulation was irrespective of the concentration 
of the toxicant or the developmental period during which exposure occurred, which 
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strongly suggested that the mechanisms of action at the level of deregulation of gene 
expression occurred in the early stages of development, since in an experimental group 
of mice the exposure period was only for two weeks in pre-matting mothers. Maternal 
accumulation of the EDs or epigenetic effects could explain the pattern of altered gene 
expression in adult testis (Lopez-Casas et al., 2012). Interestingly, the most relevant 
gene network of the deregulated genes is involved in pathologies affecting: cancer, 
developmental and endocrine system disorders. In agreement with previous studies of 
toxicity of 309 chemicals, mostly pesticides, analyzed in ES cells in vitro (Chandler et 
al., 2011), we detected that genes involved in oxidative stress response pathways such as 
Nrf2 are highly deregulated by exposure to the different EDs analyzed. Genes involved in 
testicular embryonal carcinoma progression, including matrix metalloproteinase 2 
(Mmp2) have also been recently reported as overexpressed in testicular carcinoma cells 
exposed to MEHP (Yao et al., 2012). 
Epigenetics  
Epigenetics is referred to changes in gene expression transmitted mitotically and 
meiotically without altering the DNA sequence. Consequently, epigenetic changes are key 
process both in cell differentiation and as result of environmental impact on biological 
processes (Youngson and Whitelaw, 2008; Feil and Fraga, 2012).  
The most relevant epigenetic processes are: methylation of cytosine residues on 
DNA (Bird and Wolffe, 1999), post-translational modification of histone tails (Jenuwein 
and Allis, 2001), and regulation by noncoding RNAs (especially miRNAs) (Chuang and 
Jones, 2007; Costa, 2008). All this epigenetic processes contribute to define the 
condensed or decondensed chromatin state and consequently gene expression. DNA 
methylation is the most studied mechanism of epigenetic regulation. Cytosine 
methylation primarily occurs in CpG dinucleotides in CpG-rich sequences, known as CpG 
islands that is often found near or in the gene promoter regions and usually unmethylated 
in somatic cells but differentially methylated in genes of the germline (Bird et al., 1985; 
Cross and Bird, 1995; Weber et al., 2007; Borgel et al., 2010; Popp et al., 2010; Hacket t  
et al., 2012). DNA methylation, maintained by DNA methyltransferases, is a crucial 
mechanism of epigenetic gene silencing of cell-specific genes and transposons, cell 
differentiation and development, parental genomic imprinting, X chromosome 
inactivation in mammals and maintenance of cellular pluripotency (De Carvalho et al., 
2010; Meissner, 2010; Portela and Esteller, 2010). 
The epigenetic reprogramming of PGCs development is necessary to provide these 
cells pluripotency (De Felici, 2011). Global demethylation of PGCs appears to be a key 
mechanism in this reprogramming (Popp et al., 2010; Surani and Hajkova, 2010). 
However, some genes potentially germline determinants, escape the global 
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demethylation, suggesting transgenerational transmission of DNA methylation pattern 
for these specific genes (Borgel et al., 2010). 
Epigenetic alteration, mainly changes in DNA methylation, is a common trait in 
cancer (Esteller, 2007; Sharma et al., 2010). In TGCTs, the pattern of imprinted genes is 
similar to that observed in normal embryonic cells, indicating again the embryonic origin 
of the TGC and the possible role of epigenetic changes in TGCTs in adults (van Gurp et 
al., 1994; Schneider et al., 2001; Sievers et al., 2005). The analysis of global methylation 
in TGCTs showed a profile distinct to other types of cancer affecting somatic cells 
(Ushida et al., 2011), mimicking the pattern obtained in PGCs (Okamoto and Kawakami, 
2007). However, differences are also founds between seminomas and non-seminomas. 
Seminomas show hypomethylation at the CpG islands while non-seminomas that show 
CpG island methylation at a level similar to other solid tumors (Smiraglia et al., 2002), 
which can be related with the differentiation state of PGCs in the timing of the 
transformation to tumorogenic cells as has been proposed (Rajpert-De Meyts et al., 
1998). 
Analyses of methylation levels in specific relevant genes also show alterations in 
TGCTs. In this sense, the serine protease testisin (PRSS21) expressing in premeiotic 
testicular cells and considered as tumor suppressor gene is also down-regulated in TGCTs 
(Kempkensteffen et al., 2006) probably due to the high level of hypermethylation at the 
promoter region as was detected in TGCTs (Manton et al., 2005). 
The fact that methylation patterns, and its alterations can be transmitted 
transgenerationally encourage the study of specific epigenetic changes in DNA 
methylation as a result of exposure to toxicants compounds during gonadal development 
and their potential pathological consequences. Limited studies have been carried out in 
this respect. MGMT (O6-methylguanine-DNA methyltransferase) is a DNA repair 
enzyme participating in the natural defence against cytotoxics. Loss of MGMT function 
can facilitates mutagenesis in oncogenes and tumor suppressors genes (Gerson, 2004). 
Down-regulation of MGMT due to hypermethylation of its promoter has been associated 
to different types of cancers, including testicular cancer showing higher 
hypermethylation levels in non-seminomas respect to seminomas (Smith-Sorensen et 
al., 2002; Honorio et al., 2003).  
Due to the multiple potential mechanisms of action of the EDs, diverse 
environmental epigenetic inferences have been reported (Zhang and Ho, 2011). Altered 
patterns of methylation domains of parental imprinted genes were reported in the sperm 
of mice exposed to the antiandrogen vinclozolin (Stouder and Paoloni-Giacobino, 2010). 
BPA alters the coat colour in the agouti mice (Dolinoy et al., 2007b), character highly 
sensitive to changes in methylation (Dolinoy et al., 2007a). BPA also induced in the 
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mouse hypomethylation of the Hoxa10 gene in uterine cells of females exposed in 
embryonic life (Bromer et al., 2010). Similarly, low dosage of BPA induces in neonatal 
rats hypomethylation of the phosphodiesterase Pde4d4 promoter (Ho et al., 2006). The 
exposure of mice to DEHP results in global increase of genome methylation level in the 
testis in addition to significantly increase of transcript expression of Dmnt1, Dmnt3a and 
Dmnt3b methyltransferase genes (Wu et al., 2010) which are essentials for the 
establishment of cytosine residue methylation (Li et al., 2003). Transgenerational effects 
of specific ED have been reported. The studies, contested by other reported by the 
chemical industry (Schneider et al., 2008), based on the effect on epigenetic mechanisms 
transmitted by germ cells were basically carried out by the exposure to vinclozolin 
(Anway et al., 2005; Skinner and Anway, 2005; Anway et al., 2006; Skinner, 2007; 
Skinner et al., 2011). The window of exposure during development is crucial for the 
phenotypic manifestation in adults and in successive generations. Only exposure in utero, 
during the period of formation of embryonic germ cells and their DNA methylation 
changes, affected later in adult germ cells (Cupp et al., 2003; Uzumcu et al., 2004). 
Histone methylation is a post-translational modification of these key proteins 
involved in the dynamic and stability of chromatin conformation, and potentially in 
gene expression (Greer and Shi, 2012). Recent bioinformatics approach, based on 
previously reported data of gene expression in testis in different mammals exposed to 
vinclozolin and dibutyl-phthalate versus unexposed, suggests that histone methylation 
states, and particularly the regulation of demethylase Kdm1, could participate in the 
phenotypes observed as consequence to EDs exposures and their potential 
transgenerational epigenetic inheritance (Anderson et al., 2012). Although still incipient, 
the most studied mechanism concerning histone modification is the histone H3 lysine 9 
trimethylation (H3K9me3) but hundreds of modifications with potential effects on 
epigenetic modifications should occurs considering all components of the core histones 
of the chromatin (Kubicek et al., 2006; Bannister and Kouzarides, 2011). Recently, the 
histone demethylase (H3K27) UTX has been reported as the safeguard of H3K27me3 
demethylation observed in PGCs (Sansam et al., 2003). However, histone modifications 
potentially due to EDs and effects on testis development are rarely reported.  
Based in the concept of epigenetic adaptation to exposure to adverse conditions 
during fetal development (Heijmans et al., 2009; Tobi et al., 2009), it is suggestive to 
hypothesize that the exposure to a particular ED could modify the epigenetic pattern of 
cells destined to be germ cells, such as PGCs, conditioning an "adaptive" response later 
for not differentiate, as a "hibernation", in response to the "adverse environment". Such 
circumstances might condition the maintenance of the undifferentiated state throughout 
the development and be the niche of carcinoma in situ. In adulthood, these cells 
"epigenetically misplaced" and under conditions that no longer exists: the environmental 
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element that induced such a change, could enter into proliferative processes and be the 
source of TGCS. 
The lack of an unequivocal cause-effect relationship or "epigenetic gambling" in 
terms of sensitivity or risk of these events could be due to both the genetic background of 
individuals and the ability to "adaptive resistance" of some cells from other (Martin, 
2009), even in the same genetic background as in monozygotic twins where there are 
different responses and patterns of DNA methylation (Fraga et al., 2005). 
Small non-coding RNAs  
From a biological point of view, the transcriptome and the post-transcriptional 
regulation is far more complex than originally thought. Small non-coding regulatory 
RNAs have emerged as pivotal post-transcriptional modulators of gene expression and 
are involved in diverse processes of cell differentiation and development. In particular, 
microRNAs (miRNAs) and Piwi-interacting RNAs (piRNAs) are increasingly seen as 
important elements in both gonadal development and spermatogenesis and their 
pathologies (Yu et al., 2005; Looijenga et al., 2007a; Ro et al., 2007; Hayashi et al., 
2008).  
miRNAs are small non-coding RNAs (≈ 22 nt long) that act as potent modulators 
of gene expression by targeting 3’ UTR regions of mRNAs inducing their cleavage or 
translational repression (Ambros, 2001; Ross et al., 2007; Guarnieri and DiLeone, 2008; 
Chua et al., 2009). The majority of miRNA genes are transcribed from intergenic 
regions of the genome and the primary transcripts are known as pri-miRNAs (≈ 200-
100 nt long). These pri-miRNAs are double stranded RNA molecules fold into hairpins, 
which undergoes two processing steps before to render a mature and functional molecule. 
In these processing steps are involved two members of the RNase III family of enzymes: 
DROSHA and DICER. The first processing step occurs in the nucleus, and the product of 
Drosha cleavage is named pre-miRNA (≈ 70 nt long). The pre-microRNAs are exported 
to the cytoplasm where DICER processed it, generating a double stranded structure 
without hairpins, known as miRNA duplex. One or both strands could be incorporated 
into the miRNA-induced complex (miRISC or simply RISC), whose function is to 
mediate the translational repression of mRNAs by base-pair complementarity among 
miRNA and mRNA sequences (Lau and MacRae, 2009; Snead and Rossi, 2010; 
Ladomery et al., 2011). Thousands of human genes, representing about 30% of the 
human gene set, are miRNA targets (Bentwich, 2005; Bentwich et al., 2005; Lewis et al., 
2005); individual miRNAs can suppress the production of hundreds of proteins (Selbach 
et al., 2008); more than 1000 miRNA have been predicted as well as functional 
polymorphisms within miRNA-binding sites from mRNAs (Mu and Zhang, 2012). 
Additionally, the double stranded nature of the primary miRNAs allow potential editing 
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mechanisms (adenosine to inosine) enhancing the diversity of alternative miRNAs from 
the same precursors and therefore increasing their potential in the post-transcription 
regulatory modulation of mRNA expression (Blow et al., 2006). Our recent studies 
suggest differential and active dynamics of miRNA edition and degradation associated to 
fertilization (García-López et al., submitted for publication). 
piRNAs are short RNA molecules (but larger than miRNAs) (24-32 nt long) that 
are processed in a DICER/DROSHA-independent manner and associated to PIWI 
proteins (Aravin et al., 2006). They have a role in transposable elements (TEs) 
silencing (Siomi et al., 2011) and interacting with DNA methylation during 
spermatogenesis, being basically detected in male germ cells (Aravin et al., 2006; Girard 
et al., 2006; Grivna et al., 2006; Kim, 2006), although recently they have also been 
identified in brain cells (Rajasethupathy et al., 2012). 
Small non-coding RNAs and TGCTs 
Recent studies reported the alteration of miRNA expression in different cells and 
tissues induced by diverse environmental pollutants, including some considered EDs 
(Fig.2) (Izzotti et al., 2009a; Izzotti et al., 2009b; Avissar-Whiting et al., 2010; Hou et 
al., 2011; Hou et al., 2012). Differential expression of miRNAs in human cancer 
compared with normal cells showed defined signatures associated to diagnosis, progression 
and prognosis (Calin and Croce, 2006).  
As mentioned, the origins of testicular germ cell cancer have been associated to 
dysfunctional gonocytes from fetal development. The expression of PRDM1 (also 
known as BLIMP1) is essential for PGC commitment (Ohinata et al., 2005). PRDM1 can 
be modulated by miR-let-7 family of miRNAs. In turn, LIN28 is a miRNA-binding 
protein that controls the maturation of the precursor of miR-let-7 (Heo et al., 2008; 
Newman et al., 2008; Piskounova et al., 2008; Rybak et al., 2008; Viswanathan et al., 
2008; Hagan et al., 2009). Consequently, increased level of let-7 can block the PGGs 
development. In fact, in vitro knockdown of LIN28 in the mouse reduce the number of 
PGC colonies (West et al., 2009) and also alters the expression of Prdm14, which is 
essential for germline specification. Moreover, downregulation of let-7, that is considered 
as tumor suppressor (Johnson et al., 2005; Lee and Dutta, 2007), and overexpression of 
LIN28 were linked to tumorogenesis (Chang et al., 2009; Lu et al., 2009). Consequently, 
the reported association of the overexpression of LIN28 and its homologue LIN28b with 
human germ cell tumors is consistent (West et al., 2009). Interestingly, the deregulation 
of LIN28 is only associate to germ cell malignant tumors including seminomas, 
choriocarcinomas, embryonal carcinomas and yolk-sac tumours, but not to teratomas and 
normal testis (West et al., 2009). 
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 As in other types of cancer, TGCTs present particular miRNA expression 
profiles but related with the developmental origin (McIver et al., 2012). The hsa-miR-
302 and the hsa-miR-371∼373 clusters are overexpressed in seminomas malignant 
tumors. However, the expression of miRNAs of these cluster are not altered in teratomas 
and non-malignant tumors (Palmer et al., 2010). These clusters have been involved in 
the maintenance of pluripotency and their altered expression profile could be related with 
the differentiation grade of the tumor. The miRNA expression profile is even different 
among the types of testicular tumors (Gillis et al., 2007). For example, hsa-miR-21, 
miR-155, miR-19a and miR-29a are overexpressed in type III tumors and seminomas, 
while hsa-miR-145, miR-146 and miR-133a are under-expressed in both types of 
carcinomas in comparison with control samples (Gillis et al., 2007). In general, it has 
been observed lower expression levels of miRNAs in cancers compared with control 
samples (Zhang et al., 2007; Pan et al., 2011). The relationship between the miRNA 
decay and cancer could be explained by the role of miRNA in cell differentiation and cell 
survival. But not only the miRNA expression decay was related to cancer disease, in 
other cases the up-regulation has awful consequences. In this sense, Voorhoeve et al 
(Voorhoeve et al., 2007) found increased levels of hsa-miR-371, miR-372 and miR-373 
in TGCTs. Over-expression of these miRNAs down-regulate a tumor suppressor gene 
expression involved in RAS oncogene pathway. Besides, hsa-miR-373 has been identified 
as a cell migration factor and together with hsa-miR-520c promoted tumor invasion and 
metastasis (Huang et al., 2008; Negrini and Calin, 2008). 
Further studies will be necessaries to identify the exact role of all these miRNAs 
in testicular cancer, but their expression profiles could be informative checkpoint for 
diagnosis. Serum biomarker monitoring is employed for diagnosis of TGCTs. More than a 
50% of TGCT patients have increased levels of α-fetoprotein, human chorionic 
gonadotropin and lactate dehydrogenase, however the lack of an increase does not 
exclude TGCT (Albers et al., 2011). It is necessary for a good prognosis to found specific 
biomarkers that permit a best diagnosis for TGCTs. As miRNAs presents a high stability 
in blood and other body fluids, could be good candidates to be used as biomarkers (Gilad et 
al., 2008; Brase et al., 2010; Wang et al., 2012; Zhang et al., 2012). 
Approximately 45% of the human genome is composed of repetitive elements, 
which consist of interspersed repeats and tandem repeats (Jordan et al., 2003). LINE-1 
and Alu are two major DNA repetitive elements: LINE-1 is a long group of interspersed 
nucleotide elements that constitutes at least 18% of the human genome (Kazazian, 
2004). Alu and LINE1 elements are normally heavily methylated, and contain much of 
the CpG methylation found in normal human tissues (Kazazian, 2004) both LINE-1 and 
Alu repeats were extensively unmethylated in seminomatous TGCTs, whereas in non-
seminomatous TGCTs, including two EC cell lines, the LINE-1 sequence was extensively 
unmethylated, but Alu elements were methylated (Ushida et al., 2011). Therefore, as 
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piRNAs are key molecules involved in the regulation of the transposable elements in 
germ line, the altered patterns of piRNAs in germ cells as consequence of EDs exposure 
represents an intriguing avenue of exploration. 
 
Effects of EDs on miRNA expression profiles 
As response to other external input, such as chemical drugs, EDs can deregulate 
the expression and physiological pathways of small non-coding RNAs (Hudder and 
Novak, 2008; Zhang and Dolan, 2010; Majumder and Jacob, 2011). Besides the direct 
action of EDs on the transcriptional regulation of multiple genes encoding proteins, the 
EDs could alter the balance of the fine post-transcriptional regulation of mRNAs 
mediated by non-coding small RNAs such as miRNAs. The action of deregulation of 
expression and accumulation of miRNAs by EDs can be carried out through by direct 
agonistic or antagonistic interactions with hormone receptors (HRs), which in turn 
regulate the expression of miRNAs or their biogenesis. In this sense, hormone sensitive 
cells exposed in vitro to estrogens (E2) shown deregulation of miRNAs. Some miRNAs 
are transcribed from polycistronic genes such as hsa-miR-17-92 cluster encodes 6 
miRNAs (hsa-miR-17, miR-18a, miR-19a, miR-20a, miR-19b-1, and miR-92–1). The 
pri-miRNA of this cluster and the mir-106a-363 paralogue cluster are upregulated by the 
ERα in breast cancer cells. Interestingly, the regulation occurs at the processing of 
primary forms to mature forms of miRNAs, as the pre-miR-18a is accumulated in ERα-
positive and not ERβ-positive breast cancers (Castellano et al., 2009). Furthermore, hsa-
miR-18a regulates negatively ERα due to targeting of this miRNA in the ERα mRNA. In 
this context, previous studies reported that human miR-206 regulates the post-
transcriptional expression of specific HRs as the ERα but not the ERβ, inhibiting the 
expression of hsa-miR-206 the presence of ERα agonists, also indicating a feed-back 
regulation pathway (Adams et al., 2007). In addition to the interaction between ERs and 
miRNAs in breast cancer, new studies show the association of miRNAs with other steroid 
receptors such as androgen receptor, progesterone receptor, glucocorticoid receptor in 
non-breast cancers (see review by (Tessel et al., 2010).  
Independently of the interaction between HRs and specific miRNAs, impaired 
biogenesis of miRNAs can be hormonally mediated. The processing of miRNAs can be 
repressed by the binding of DROSHA to ERα (Yamagata et al., 2009). In some hormone-
dependent cancers the global deregulation of miRNAs has been associated to the 
alterations in the expression of two key enzymes: DROSHA and DICER, involved in the 
miRNA processing. Down-regulated DICER has been found in breast cancers (Grelier et 
al., 2009) or both DROSHA and DICER in ovarian cancers (Merritt et al., 2008) and 
subtypes of breast cancers (Dedes et al., 2011). However, opposite regulation of DICER 
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was detected in prostate adenocarcinoma (Chiosea et al., 2006).  
Recent studies reported that two well known EDs such as DDT and BPA alter the 
pattern of expression of multiple miRNAs of human MCF-7 including the estrogen–
regulated hsa-miR-21 considered as onco-miR in breast cancer (Tilghman et al., 2012). 
Altered expression profiles of miRNAs linked to EDs exposure were also observed 
(Ficociello et al., 2010; Choi et al., 2011; Zhang and Ho, 2011). Specifically, it was 
observed overexpression of hsa-miR-146a in two placental cell lines in response to BPA 
exposure (Avissar-Whiting et al., 2010). Such overexpression, leads slower proliferation 
and increase the sensitivity to other damaging compounds (Avissar-Whiting et al., 2010). 
Furthermore, other miRNAs seem to be affected by BPA exposure. Three members of 
let-7 miRNA family increased their expression levels after the BPA exposure (Avissar-
Whiting et al., 2010). As mentioned above, the equilibrium among let-7 family members 
and LIN-28 is critical for regulating the differentiated cell state. Changes in this 
equilibrium, may originate altered rates of cell proliferation (Melton et al., 2010; 
Newman and Hammond, 2010; Viswanathan and Daley, 2010; Wang et al., 2010; Chen et 
al., 2011; Pan et al., 2011). However, let-7 is considered as tumor suppressor (Zhang et 
al., 2007) and consequently the possible effect of deregulation of let-7 BPA-mediated in 
testis could have be involved in other pathologies of TDS different to TGCTs. Similar 
alteration in miRNA expression has been reported in Sertoli cells exposed to 
nonylphenol. A third of miRNAs analyzed showed altered expression after exposure to 
this ED (Choi et al., 2011). 
Recent reports show that epigenomic alterations may be parallel to those found in 
miRNA profiles and explained by crosstalk between epigenetic regulation and regulation 
of miRNA expression (Chuang and Jones, 2007; Fabbri, 2008), including specific 
patterns in testis (Schilling and Rehli, 2007). 
All these studies clearly indicate a correlation between miRNA expression, and as a 
result on the corresponding products of the mRNA targets, and the hormone regulation 
pathways. Consequently, external factors with potential effects on hormonal balance, 
such as EDs, can alter the expression of miRNAs and hence the levels of mRNAs and the 
corresponding coded proteins. The harmful effects of EDs in miRNA expression profiles 
may be additional cause of altered proliferation cell rates on the reproductive system and 
potential source of TGCTs. 
Concluding Remarks 
In mammals, testis development and germ cell fate is a complex and highly 
regulated genetically from early embryonic stages to adulthood (Kimble and Page, 2007). 
Consequently, disturbances in any of the regulatory pathways involved functional 
changes mediated by deregulation of gene expression, leading to reproductive 
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dysfunctions and pathologies such as testicular cancer (Fig 3). In turn, the different 
regulatory mechanisms, including hormones, operate in a variable way in different stages 
of development. What is evident is that from the beginning of the primordial germ cell 
formation and differentiation in embryonic life there are key windows in the process, 
and therefore there are points of high risk susceptible of deleterious disruption by 
environmental signals. 
The EDs and other potential reprotoxicants can alter the homeostasis necessary 
for correct testicular development and normal differentiation of germ cells but at 
different levels and developmental windows. Moreover, the synergistic effects of 
combinations of these compounds broaden the landscape of potential risk. The 
mechanisms of action of these compounds, leading to various pathologies in male 
gonadal development and function are multiple, but with a common core as deregulation 
of the expression of multiple genes. In these dysfunctional processes, different pathways 
could be affected: by direct action on transcriptional regulators, potentially mediated by 
hormones, and/or acting as post-transcriptional regulators such as those that affect 
miRNAs and piRNAs. Moreover, epigenetic deregulation may generate changes that in 
some cases may be inherited and transmitted transgenerationally (Youngson and 
Whitelaw, 2008). All these factors could contribute to the aetiology of pathologies 
manifested as germ cell tumors, along with intrinsic risk genomic factors in individuals or 
populations. 
All this complex network of cause-effect can be evidenced by new high throughput 
approaches at molecular, cellular and developmental levels. However, considering the 
difficulties in the implementation of in vitro systems in germ cells development, the 
abundance and increased risk factors in our environment and their additive or synergistic 
effects, the goal is foreseen a long way but as a great challenge. 
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 Table 1. Genes deregulated in PGCs after in vitro exposure to different toxicants 
identified by differential screening of gene expression from cDNA libraries. MEHP 
(mono-2-ethylhexyl phthalate), ADR (adriamycin) ENU (N-ethyl-N-nitrosourea) 
 
COMPOUND GENE SYMBOL GENE NAME REGULATION 
MEPH Rpl8 ribosomal protein L8 UP 
MEPH Rpl24 ribosomal protein L24 UP 
MEPH mt-Nd1 ND1 NADH dehydrogenase subunit 1 DOWN 
MEPH Rpl10a ribosomal protein L10A DOWN 
MEPH Eif2s2 Eukaryotic translation initiation factor 2, subunit 2 (beta) DOWN 
MEPH Fau Finkel-Biskis-Reilly murine sarcoma virus (FBR-MuSV) ubiquitously expressed (fox derived) DOWN 
MEPH mt-Co3 Cytochrome Oxidase III, COX3 DOWN 
ENU Rplp1 Ribosomal protein, large, P1 UP 
ENU Rpl31 ribosomal protein L31 UP 
ENU Rpl28 ribosomal protein L28 UP 
ENU Rpl35 ribosomal protein L35 UP 
ENU Rps17 ribosomal protein S17 UP 
ENU mt-Co3 Cytochrome Oxidase III, COX3 DOWN 
ENU Rps8 ribosomal protein S8 DOWN 
ENU mt-Co1 cytochrome c oxidase subunit I DOWN 
ENU mt-Nd2 NADH dehydrogenase subunit 2, mitochondrial DOWN 
ENU Sod1 superoxide dismutase 1, soluble DOWN 
ADR Hbb-Y hemoglobin Y, beta-like embryonic chain UP 
ADR Rpl41 ribosomal protein L41 DOWN 
 
Figure legends  
Figure 1. In mice, the sexual dimorphism of the fetal gonads is clearly evident at 13.5 
dpc. The mesonephros, with an important role in sexual differentiation, is associated to 
the left of each gonad.  
Figure 2. miRNAs deregulated in different tissues after exposure of various contaminant 
agents including EDs, as is BPA. In some miRNAs their expression were altered regardless 
of the inducer chemical agent or environmental factor (in red).  
Figure 3. Complex interactions between different factors and mechanisms of action of 
EDs can lead to various pathologies in the development of testis, including germ cell 
tumors. 

Altered miRNA expression
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miR-34, miR-99, miR-122, miR-123, 
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